Replies to post #533413 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Thanks for posting. I would argue that it is advisable to wait for the independent professional analysis.

The forthcoming independent peer review of the murcidencel (DCVax-L) P3 study will provide a reliable analysis of the trial design and its data. Licensed independent physicians and qualified skilled statisticians can explain the significance of this landmark study.

The peer-reviewed publication will expand on the SNO paper with a more comprehensive report.

https://academic.oup.com/neuro-oncology/article/24/Supplement_7/vii66/6826190?login=false





https://virtualtrials.org/dcvax.cfm